These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 6876861)

  • 1. Cardioplegia and slow calcium-channel blockers. Studies with verapamil.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1983 Aug; 86(2):252-61. PubMed ID: 6876861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowering the calcium concentration in St. Thomas' Hospital cardioplegic solution improves protection during hypothermic ischemia.
    Robinson LA; Harwood DL
    J Thorac Cardiovasc Surg; 1991 Feb; 101(2):314-25. PubMed ID: 1992242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced myocardial protection with high-energy phosphates in St. Thomas' Hospital cardioplegic solution. Synergism of adenosine triphosphate and creatine phosphate.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1987 Mar; 93(3):415-27. PubMed ID: 3821150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium antagonists and myocardial protection during cardioplegic arrest.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    Adv Myocardiol; 1985; 6():545-62. PubMed ID: 3992050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium antagonists and myocardial protection: a comparative study of the functional, metabolic and electrical consequences of verapamil and nifedipine as additives to the St. Thomas' cardioplegic solution.
    Yamamoto F; Manning AS; Crome R; Braimbridge MV; Hearse DJ
    Thorac Cardiovasc Surg; 1985 Dec; 33(6):354-9. PubMed ID: 2417372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium antagonists and myocardial protection: diltiazem during cardioplegic arrest.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    Thorac Cardiovasc Surg; 1983 Dec; 31(6):369-73. PubMed ID: 6198759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of L-arginine on myocardial recovery after cardioplegic arrest and ischemia under moderate and deep hypothermia.
    Amrani M; Gray CC; Smolenski RT; Goodwin AT; London A; Yacoub MH
    Circulation; 1997 Nov; 96(9 Suppl):II-274-9. PubMed ID: 9386110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine phosphate: an additive myocardial protective and antiarrhythmic agent in cardioplegia.
    Robinson LA; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Feb; 87(2):190-200. PubMed ID: 6694410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium antagonists and hypothermia: the temperature dependency of the negative inotropic and anti-ischemic properties of verapamil in the isolated rat heart.
    Hearse DJ; Yamamoto F; Shattock MJ
    Circulation; 1984 Sep; 70(3 Pt 2):I54-64. PubMed ID: 6744570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temperature-dependence of the effect of trifluoperazine as a protective agent during cardioplegia in the isolated working rat heart.
    Beresewicz A; Mistarz K; Demkow M
    Biomed Biochim Acta; 1990; 49(10):1039-48. PubMed ID: 2080904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium and cardioplegia. The optimal calcium content for the St. Thomas' Hospital cardioplegic solution.
    Yamamoto F; Braimbridge MV; Hearse DJ
    J Thorac Cardiovasc Surg; 1984 Jun; 87(6):908-12. PubMed ID: 6727412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hyperpolarized cardiac arrest with ATP-sensitive potassium channel opener on myocardial protection during CPB].
    Yu T; Liu X; Yu Z; Yang S; Ye Y; Yang X; Gao Z
    Zhonghua Wai Ke Za Zhi; 2000 Dec; 38(12):931-4. PubMed ID: 11832201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of the ischemic myocardium: cold chemical cardioplegia, coronary infustates and the importance of cellular calcium control.
    Jynge P
    Thorac Cardiovasc Surg; 1980 Oct; 28(5):310-21. PubMed ID: 6161429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine and cardioplegia: rat heart studies with the St Thomas' cardioplegic solution.
    Yamamoto F; Manning AS; Braimbridge MV; Hearse DJ
    Cardiovasc Res; 1983 Dec; 17(12):719-27. PubMed ID: 6661743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial protection with pinacidil induced hyperpolarized arrest during cardiopulmonary bypass.
    Yu T; Yu Z; Liu X; Yang S; Ye Y
    Chin Med J (Engl); 2001 Dec; 114(12):1245-8. PubMed ID: 11793844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroids and cardioplegia. An experimental evaluation of glucocorticoid supplementation to cardioplegic solutions in clinical use.
    Sellevold OF; Jynge P
    Thorac Cardiovasc Surg; 1985 Apr; 33(2):65-70. PubMed ID: 2409626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of the chronic hypoxic immature rat heart during global ischemia.
    Karck M; Ziemer G; Zoeller M; Schulte S; Juergens KD; Weisser H; Haverich A
    Ann Thorac Surg; 1995 Mar; 59(3):699-706. PubMed ID: 7887715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution.
    Maruyama Y; Chambers DJ
    Interact Cardiovasc Thorac Surg; 2008 Oct; 7(5):745-9. PubMed ID: 18550603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protection of the myocardium during ischemic arrest. Dose-response curves for procaine and lignocaine in cardioplegic solutions.
    Hearse DJ; O'Brien K; Braimbridge MV
    J Thorac Cardiovasc Surg; 1981 Jun; 81(6):873-9. PubMed ID: 7230856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.